Kaplan–Meier plots of the MSKCC 2020 lung adenocarcinoma cohort (available dataset on cBioportal.org) regarding the survival curves of patients with an EGFR mutation, HER2 mutation, or HER2 amplification are shown in Figure 1. Here, ERBB2 is linked to lung adenocarcinoma.